簡(jiǎn)要描述:
anti-8-OHdG(8-hydroxy-2-de-axyguanine)8-羥基脫氧鳥(niǎo)苷50ug/100ug
更新時(shí)間:2024-08-17;廠商性質(zhì):經(jīng)銷(xiāo)商;覽量:1238
8-羥基脫氧鳥(niǎo)苷 anti-8-OHdG(8-hydroxy-2-de-axyguanine)
Anti-AT1R(Angiotensin II Type 1 Receptor) 血管緊張素Ⅱ-1型受體抗體 50ug/100ug
Anti-ATF1 (Activating Transcription Factor1) 活化復(fù)制因子1抗體 50ug/100ug
Anti-ATF2 (Activating Transcription Factor2) 活化復(fù)制因子2抗體 50ug/100ug
Anti-ATF3 (Activating Transcription Factor3) 活化轉(zhuǎn)錄因子3抗體 50ug/100ug
Anti-B7-H1/PDL1/CD274(programmed death ligand 1) 程序性死亡配體1抗體 50ug/100ug
Anti-B7-H4 ( V-set domain containing T cell activation inhibitor 1 ) B7H4抗體 50ug/100ug
Anti-BACE/ASP2 β分泌酶抗體 50ug/100ug
Anti-Bad (BCL-xL/BCL-2-associated death promoter) 相關(guān)死亡促進(jìn)因子Bad抗體 50ug/100ug
anti-Bak(BCL2 homologous antagonist/killer) Bcl-2同源拮抗劑Bak抗體 50ug/100ug
Anti-BADH2 (Betaine-aldehyde dehydrogenase ) BADH2抗體 50ug/100ug
8-羥基脫氧鳥(niǎo)苷 anti-8-OHdG(8-hydroxy-2-de-axyguanine)
Anti-Bassoon/RCN(zinc finger protein) 鋅指蛋白231抗體 50ug/100ug
Anti-Bax (Bcl-2 Assaciated X protein) Bax(小鼠來(lái)源抗體) 50ug/100ug
Anti-Bax(Bcl-2 Assaciated X protein) Bax抗體 50ug/100ug
Anti-Bcl-2(B cell lymphoma/leukemia-2) Bcl-2抗體 50ug/100ug
Anti-BCRP/ABCG2/BXP-21(breast cancer resistance protein) 乳腺癌耐藥相關(guān)蛋白抗體 50ug/100ug
Anti-BDNF (Brain-derived Neurotrophin factor) 腦源神經(jīng)營(yíng)養(yǎng)因子/腦衍化神經(jīng)營(yíng)養(yǎng)因子 50ug/100ug
Anti-Beta-casein(β-casein) β-酪蛋白(抗體)兔抗山羊、綿羊 50ug/100ug
anti-bov β-lactoglobulin(bov beta-lactoglobulin) 牛β-乳球蛋白抗體 50ug/100ug
anti-bov Casein 抗牛酪蛋白抗體 50ug/100ug
Anti-BFGF/FGF-2 堿性成纖維細(xì)胞生長(zhǎng)因子抗體 50ug/100ug
anti-8-OHdG(8-hydroxy-2-de-axyguanine)
間接染色法如果檢查未知抗原,先用已知未標(biāo)記的特異抗體(*抗體)與抗原標(biāo)本進(jìn)行反應(yīng),作用一定時(shí)間后,洗去未反應(yīng)的抗體,再用標(biāo)記的抗抗體即抗球蛋白抗體(第二抗體)與抗原標(biāo)本反應(yīng),如果*步中的抗原抗體互相發(fā)生了反應(yīng),則抗體被固定或與熒光素標(biāo)記的抗抗體結(jié)合,形成抗原-抗體-抗抗體復(fù)合物,再洗去未反應(yīng)的標(biāo)記抗抗體,在熒光顯微鏡下可見(jiàn)熒光。在間接染色法中,*步使用的未用熒光素標(biāo)記的抗體起著雙重作用,對(duì)抗原來(lái)說(shuō)起抗體的作用,對(duì)第二步的抗抗體又起抗原作用。如果檢查未知抗體則抗原標(biāo)本為已知的待檢血清為*抗體,基他步驟和檢查抗原相同。
anti-8-OHdG(8-hydroxy-2-de-axyguanine)